An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam
NCT00761774
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
108
Enrollment
INDUSTRY
Sponsor class
Conditions
Epilepsy
Interventions
DRUG:
Brivaracetam
Sponsor
UCB Pharma